Aren Fischer
Overview
Explore the profile of Aren Fischer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fischer A, Mac S, Freiman E, Marshall J, Rand K, Ramos-Goni J
Pharmacoecon Open
. 2024 Oct;
9(1):41-56.
PMID: 39377864
Introduction: Vedolizumab is a gut-selective anti-lymphocyte trafficking biologic indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD) in Canada. Objective:...
2.
Fenu E, Lukyanov V, Acs A, Radu X, Stypa S, Fischer A, et al.
Pharmacoecon Open
. 2022 Apr;
6(4):519-537.
PMID: 35474178
Background And Objectives: Ulcerative colitis is highly prevalent in Canada and cost-effective ulcerative colitis therapies are warranted. Vedolizumab subcutaneous (SC) formulation was recently approved for ulcerative colitis maintenance therapy. We...
3.
Lee J, Amin S, Erdmann M, Kukaswadia A, Ivanovic J, Fischer A, et al.
Patient Prefer Adherence
. 2020 Apr;
14:725-735.
PMID: 32308377
Background: Omalizumab is a treatment option for pediatric and adult patients with moderate to severe allergic asthma poorly controlled with standard inhaled therapies. Clinical trials and observational studies have demonstrated...
4.
Caffery B, Srinivasan S, Reaume C, Fischer A, Cappadocia D, Siffel C, et al.
Ocul Surf
. 2019 Mar;
17(3):526-531.
PMID: 30825521
Purpose: Population-based cross-sectional survey in Ontario to estimate the 2016 prevalence of dry eye disease (DED) and associated risk factors among adults in Canada. Methods: We emailed the 5-Item Dry...
5.
Yoshida E, Mason A, Peltekian K, Shah H, Thiele S, Borrelli R, et al.
CMAJ Open
. 2018 Dec;
6(4):E664-E670.
PMID: 30578275
Background: There is a wealth of data documenting the epidemiology of primary biliary cholangitis (PBC) globally; however, the epidemiology of PBC has not been as well studied in Canada. Our...
6.
Fischer A, Cloutier M, Goodfield J, Borrelli R, Marvin D, Dziarmaga A
J Rheumatol
. 2016 Nov;
44(1):95-101.
PMID: 27803136
Objective: To estimate the direct healthcare cost and resource use from the public payer perspective between patients with incident gout and matched gout-free patients in Ontario. Methods: Patients with incident...